Positive clinical trial results fromGilead Sciences ( GILD ) andCelgene ( CELG ) released over the weekend lifted biotechnology ETFs to their biggest one-day gains in as many as three
Read the original post:
Gilead Sciences And Celgene Liven Up Biotech ETFs